New York, May 21, 2026, 05:05 EDT
- Rocket Lab has launched a program to offer as much as $3 billion in common stock and forward sales.
- Shares dropped in after-hours trading following the filing, pulling back some of a strong 2026 run.
- SpaceX’s public IPO filing gave investors a new metric for sizing up launch and satellite firms.
Rocket Lab Corp shares dropped before the open Thursday as the space company disclosed plans to sell as much as $3 billion in common stock. The filing stoked dilution fears and came as SpaceX’s IPO registration put new size pressure on the space business. Rocket Lab was trading near $126.75 early, down from its Wednesday close at $134.28.
Timing is key here. Rocket Lab had turned into a big public play on launch services, satellites, and space hardware with a defense angle, and Benzinga said the stock was up around 92% year-to-date before the late-Wednesday filing.
Nasdaq’s main trading had not started as of the dateline. Premarket hours, according to the exchange, are from 4:00 a.m. to 9:30 a.m. Eastern, before regular trading starts at 9:30 a.m. The 2026 holiday schedule from Nasdaq shows the next U.S. market closure is Memorial Day, Monday, May 25.
Rocket Lab disclosed in an 8-K it signed an equity distribution agreement with several banks and brokerages. The setup allows Rocket Lab to sell shares in the open market, either through agents or directly to the firms. This at-the-market method means the company can sell stock over time, matching going prices, instead of a single block sale.
Rocket Lab said it plans to use the funds for growth, possible deals, and working capital. The filing also details forward-sale deals that let banks borrow and sell Rocket Lab shares upfront, hedging before Rocket Lab gets the money or closes the deal.
Rocket Lab’s latest numbers aren’t showing weakness. The company posted first-quarter revenue of $200.3 million, up 63.5% from last year. Backlog hit a record $2.2 billion, with liquidity above $2 billion. Guidance for second-quarter revenue came in at $225 million to $240 million.
Still, new shares can hit current holders. Dilution leaves them with less of the company, and Rocket Lab warned in its prospectus that sales in the program, or future sales, might push down the share price. The company also said more stock could cut earnings per share if the cash raised does not bring in enough revenue to make up for it.
SpaceX moved forward with its IPO plans, filing publicly on Wednesday and saying it will list on Nasdaq, Reuters said. The filing marks the first time SpaceX shares would go to public investors.
SpaceX’s revenue is on a bigger scale. Investor’s Business Daily, quoting the prospectus, put first-quarter revenue at $4.694 billion and showed $18.674 billion for 2025 revenue. Starlink made up a large part of that, according to the report.
Rocket Lab faces a tougher comp set now. Shares dropped more than 6% in after-hours trade, MarketWatch said, after SpaceX’s filing. Other space stocks, including Voyager Technologies and Firefly Aerospace, were down too but losses weren’t as steep.
Wall Street is mixed on SpaceX. Dan Ives at Wedbush Securities says the IPO puts SpaceX right in two big growth areas. But Dennis Dick from Triple D Trading takes a different view; he finds the idea of a $2 trillion valuation “a little scary.” Reuters
Rocket Lab’s risk boils down to investor reaction. If the $3 billion plan looks like smart funding after the stock’s run, it gives Rocket Lab more capacity for deals, Neutron work and defense contracts. If they see it as flooding the market too early, the stock may stay under pressure, backlog or not.
